Enterprise Europe Network

French company offers connected drug dispenser of the prescribed dose with digital solution for patients’ telesurveillance

Country of origin:
Country: 
FRANCE
Opportunity:
External Id: 
TOFR20190919001
Published
22/10/2020
Last update
03/12/2020
Expiration date
30/09/2021

Keywords

Partner keyword: 
Computer Software
Internet Technologies/Communication (Wireless, Bluetooth)
Applications for Health
Clinical Research, Trials
Health information management
Drug delivery and other equipment
Hospital and other institutional management
Computer-aided diagnosis and therapy
Other medical/health related (not elsewhere classified)
Safety for the elderly
Other information technology and computer service activities
Other human health activities
EXPRESS YOUR INTEREST

Summary

Summary: 
French e-Health company offers a global program gathering a connected oral drug dispenser of the prescribed dose and a digital solution for patients’ telesurveillance. This smart connected dispensing device guarantees the packaging of pharmaceutical products and connects patients continuously to healthcare professionals in real time, while ensuring the correct dispensation of their prescribed doses evolution. The company is seeking technical cooperations or commercial agreements.

Description

Description: 

Ambulatory/home cares development and oral drugs dispensation at home for the treatment and the management of serious diseases are the major orientation of healthcare system worldwide. In this context, adaptation of prescribed dose in real time and the prevention of the dispensation errors are a challenge especially for oral drugs which are complex in terms of scheme of administration, need a close monitoring of adverse events, a prevention of complications and a management of adherence.
In this situation, patient and healthcare professionals (hospital sector and ambulatory sector) need an efficient information system for an optimal organisation of cares and for an appropriate patients’ telesurveillance, checking adherence to the treatment and early alerting of adverse events or complications.

To cover this need and meet such evolution, the company is developing a smart connected dispensing device that guarantees the security and the data Track of the packaging of pharmaceutical products and connects patients continuously to healthcare professionals in real time, while ensuring in real time the correct dispensation of their prescribed oral doses in a secure way at home.
The application of the offer could be tailored for any diseases treated with oral drugs in at risk patients population who need scrutiny.

At the moment, experiments are led in oncology in 2 centers in France with the first inclusion of patient in May 2020. The patient-centered approaches applied to the development of the remote-care software are positive for the patients and are communicated in a poster during a conference in psycho-oncology in November 2019.

The offer is adaptable: it could be the connected dispensing device and secured packaging alone associated with a remote-care software developed by a partner or a remote-care software alone for the digital coordination of cares and patients reported outcomes (treatment adherence included) or both of them.

The partnership could be with:

- healthcare institutions which have the project to implement digital organisation of cares and patients’ drugs telesurveillance,

- others SMEs which want to integrate remote-care sofware technologie or connected device with their apps to monitor adherence to drug and surveillance of patients,

- pharma companies in the frame of their randomized clinical trials or of their study in real life conditions for oral drugs which need specific safety monitoring.

The company is interested in technical cooperation agreement, research cooperation agreement or commercial agreement with technical assistance.

Advantages & innovations

Cooperation plus value: 
The offered digital and connected solutions meet these unmet needs and trends. Advantages of such digital and connected solutions : - interoperable with the healthcare network and with any connected devices, - tailored to any diseases which necessitate treatment with oral drug with real time dose adjustment in a secure way, - it would impact on the organisation of healthcare system hospital and ambulatory care, - it would bring relevance of care with a better allocation of healthcare resources utilisation for the most demanding patients population, - it would bring quality of care by preventing / mitigating adverse events or complications, - it would bring equity in terms of access of care, - it would improve outcomes and quality of life of patients and helpers, - it would improve adherence to the treatment, enhance security, limit the wastage of expensive oral drugs and reduce costs of care, - it would avoid non-relevant sanitary transportation and sparing costs/time associated.

Stage of development

Cooperation stage dev stage: 
Available for demonstration

Partner sought

Cooperation area: 
The company is looking for partners to implement the proposed digital and connected solutions in response to unmet needs. The partnership could have the objective to generate more evidence to demonstrate the value of the solution by extension to others diseases and others patients population of interest. This technology could be also use against drug’s conterfeit Three types of partners can be sought : - healthcare institutions (hospitals, care-network, public, private, associations) which has the project to implement digital organisation of cares, - others SMEs which want to integrate remote-care sofware technologie or connected device with their apps to monitor adherence to drug and surveillance of patients, - pharma companies in the frame of their Randomized Clinical Trials in R&D.

Type and size

Cooperation task: 
SME 11-50,R&D Institution,SME <10,251-500,SME 51-250